Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer

Clinical trial NCT02162667 · COMPLETED

Trial details

NCT number: NCT02162667
Sponsor: Celltrion
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HER2-positive Carcinoma of Breast

Start date: 2014-06-01
Primary completion: 2016-05-26
Enrollment: 562

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.